Back

Impact of Ebola virus nucleoprotein on VP40 virus-like particle production: a computational approach

Liu, X.; Stahelin, R. V.; Pienaar, E.

2023-08-09 systems biology
10.1101/2023.08.09.552607 bioRxiv
Show abstract

Ebola virus (EBOV) protein VP40 can assemble and bud in the form of virus-like particles (VLPs) when expressed in the absence of other EBOV proteins in mammalian cells. When nucleoprotein (NP) is co-expressed, VLPs will contain inclusion-body (IB) cores, and VLP production can be increased. However, the mechanism of how NP impacts VLP production remains unclear. Here, we use a computational approach to study NP-VP40 interactions. We find that NP may enhance VLP production through stabilizing VP40 filaments and accelerating the VLP budding step. Also, both the relative timing and amount of NP expression compared to VP40 are important for the effective production of IB-containing VLPs. We further find that there exists an optimum NP/VP40 expression ratio, and that earlier expression of NP compared to VP40 will produce IB-containing VLPs more efficiently. We conclude that disrupting the relative timing and amount of NP and VP40 expression could provide new avenues to treat EBOV infection. This work provides quantitative insights into how EBOV proteins interact and how those interactions could impact virion generation and drug efficacy.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.